Fingerprint
Dive into the research topics of 'Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection
Emma S. Winkler, Pavlo Gilchuk, Jinsheng Yu, Adam L. Bailey, Rita E. Chen, Zhenlu Chong, Seth J. Zost, Hyesun Jang, Ying Huang, James D. Allen, James Brett Case, Rachel E. Sutton, Robert H. Carnahan, Tamarand L. Darling, Adrianus C.M. Boon, Matthias Mack, Richard D. Head, Ted M. Ross, James E. Crowe, Michael S. Diamond
- Division of Infectious Diseases
- Bursky Center for Human Immunology & Immunotherapy Programs (CHiiPs)
- Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
- Institute of Clinical and Translational Sciences
- COVID-19 Researchers
- Siteman Cancer Center
- Genome Technology Access Center (GTAC)
- Institute for Public Health
- McDonnell Genome Institute (MGI)
- Rheumatic Diseases Research Resource-Based Center
- DBBS - Immunology
- DBBS - Molecular Microbiology and Microbial Pathogenesis
Research output: Contribution to journal › Article › peer-review
153
Scopus
citations